14 hrs ago | Wall St. Cheat Sheet
Do Merck's Major Stockholders See $40 Per Share Down the 2012 Road?
For the year-to-date, Merck & Co. Inc.'sA shares are down 0.29 percent. On Tuesday, Bloomberg reported that Merck has made a $25 per share offer onA Amylin Pharmaceuticals .
18 hrs ago | Freshnews
Merck to Present at Sanford C. Bernstein 28th Strategic Decisions Conference
Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at: http://www.merck.com/investors/events-and-presentations/home.html . Today's Merck is a global healthcare leader working to help the world be well.
RedHill Biopharma Announces a Successful Pivotal Bioequivalence Trial ...
TEL AVIV, Israel -- -- RedHill Biopharma Ltd. , an emerging Israeli biopharmaceutical company focusing primarily on development of late clinical-stage , patent protected, new formulations and combinations of existing drugs, announces positive results in a pivotal bioequivalence clinical trial with RHB-103, an oral thin-film formulation of ... (more)
IntelGenx Corp. Achieves Positive Pivotal Study Results for...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAINT LAURENT, Quebec, May 29, 2012 -- IntelGenx Corp.
Drugmakers vulnerable if U.S. health law revoked
Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the U.S. Supreme Court strikes down part or all of the 2010 law.
Here's Why Disney and Merck are Leading the Dow Higher
Walt Disney Co.'s "The Avengers" might meet its box office forecast of $40 million over the coming three-day weekend, but Sony Pictures' "Men in Black 3" is projected to gross around $80 million in North America, which would pretty much double that of the former title, says the Los Angeles Times .
New CEO takes the helm at biotech giant Amgen
WESTLAKE VILLAGE, Calif. -- Biotech drugmaker Amgen Inc. introduced new CEO Bob Bradway to shareholders Wednesday at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade running the world's largest biotech company.
Merck: Manufacturing Portfolio Health With Dividend Income
Shares of Merck & Co. , the second-largest U.S. drugmaker, have been on a bit of a swoon lately showing weakness even on a broad market rally like Monday.
National Center for Public Policy Res...
More on Merck and Obamacare...
Bridgewater, NJ / Washington, D.C. - The National Center for Public Policy Research plans to question Merck executives over the company's lobbying for the ObamaCare legislation Tuesday, May 22 at the company's annual shareholder meeting.
FDA Approves New Labeling for ISENTRESSA (raltegravir) to Include...
FDA Approves New Labeling for ISENTRESSA to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated WHITEHOUSE STATION, N.J. -- -- Merck , known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration approved a labeling ... (more)
Parents of Propecia sucide victim join in Kevin Malley's Merck hunger-strike
As 30-year-old Propecia victim Kevin Malley begins the second week of his hunger strike outside the doors of drug maker Merck & Co., others whose lives have also been devastated by the hair growth drug are joining his protest at the company's headquarters in Whitehouse, N.J. Family and friends of Randy Santmann, who took his own life at age 22 ... (more)
Kevin Malley's hunger-strike at Merck highlights Propecia's devastating effects
After reading the Examiner's coverage on the devastating side effects of Merck & Co.'s hair-growth drug Propecia, more men are now coming forward to say they are also unsuspecting victims.
Recently released market study: Piramal Life Sciences Limited...
The company is principally engaged in the drug discovery and drug development in four therapeutic areas, namely, cancer, diabetes, inflammation and infectious diseases.
Propecia victim launches hunger strike at Merck NJ headquarters
A 30-year-old Las Vegas man who says his life was ruined after taking the hair-loss drug Propecia has launched a hunger strike at the corporate headquarters of the drug's maker -- pharmaceutical giant Merck & Co.
Merck & Co., Inc. to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia WHITEHOUSE STATION, N.J.-- --Merck , known as MSD outside the United States and Canada, announced today that Alex Kelly, senior vice president, investor relations, is scheduled ... (more)
Citing "enhanced prospects for new drug approvals and a favorable outlook for mergers and acquisitions," S&P Capital IQ extolled the virtues of investing in the biotechnology sector and highlighted several ETFs offering exposure to biotech stocks in a new research note.
3 Dow Movers with News You Must Know
McDonald's Corp. affirms a report in China Daily that says it increased the four different products by 1 yuan , at the end of April, marking the second price bump so far this year.
Customer Interaction Solutions
Aptiv Solutions Announces the Appointment of Luis Gutierrez as...
Aptiv Solutions, a biopharmaceutical and medical device development services company , and leader in adaptive clinical trial design, simulation and execution , announced today the appointment of Luis T. Gutierrez, Jr.
Merck & Co., Inc.'s Australia Win in Vioxx Ruling is Upheld by Court
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Merck & Co.
Roche down after ending cholesterol drug trials
Roche Holding AG fell the most in almost six months in Zurich trading after abandoning development of an experimental cholesterol drug as a late-stage trial showed it wasn't working.